ARESTIN Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Arestin, and what generic alternatives are available?
Arestin is a drug marketed by Orapharma and is included in one NDA. There are two patents protecting this drug.
This drug has sixteen patent family members in thirteen countries.
The generic ingredient in ARESTIN is minocycline hydrochloride. There are fifteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the minocycline hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Arestin
A generic version of ARESTIN was approved as minocycline hydrochloride by WATSON LABS on December 30th, 1991.
Summary for ARESTIN
| International Patents: | 16 |
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 90 |
| Clinical Trials: | 7 |
| Patent Applications: | 3,237 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for ARESTIN |
| What excipients (inactive ingredients) are in ARESTIN? | ARESTIN excipients list |
| DailyMed Link: | ARESTIN at DailyMed |
Recent Clinical Trials for ARESTIN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Minnesota | Phase 4 |
| Bausch Health Companies, INC. | Phase 4 |
| University of Minnesota - Clinical and Translational Science Institute | Phase 4 |
Pharmacology for ARESTIN
| Drug Class | Tetracycline-class Drug |
Anatomical Therapeutic Chemical (ATC) Classes for ARESTIN
US Patents and Regulatory Information for ARESTIN
ARESTIN is protected by two US patents.
Patents protecting ARESTIN
Dispensing apparatus and cartridge
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Dispensing apparatus and cartridge with deformable tip
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orapharma | ARESTIN | minocycline hydrochloride | POWDER, EXTENDED RELEASE;DENTAL | 050781-001 | Feb 16, 2001 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| Orapharma | ARESTIN | minocycline hydrochloride | POWDER, EXTENDED RELEASE;DENTAL | 050781-001 | Feb 16, 2001 | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ARESTIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Orapharma | ARESTIN | minocycline hydrochloride | POWDER, EXTENDED RELEASE;DENTAL | 050781-001 | Feb 16, 2001 | See Plans and Pricing | See Plans and Pricing |
| Orapharma | ARESTIN | minocycline hydrochloride | POWDER, EXTENDED RELEASE;DENTAL | 050781-001 | Feb 16, 2001 | See Plans and Pricing | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ARESTIN
See the table below for patents covering ARESTIN around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Spain | 2427272 | See Plans and Pricing | |
| Brazil | 0308859 | Aparelho de distribuição e cartucho | See Plans and Pricing |
| Australia | 2003223384 | DISPENSING APPARATUS AND CARTRIDGE | See Plans and Pricing |
| Japan | 4749672 | See Plans and Pricing | |
| European Patent Office | 1489988 | DISTRIBUTEUR ET CARTOUCHE (DISPENSING APPARATUS AND CARTRIDGE) | See Plans and Pricing |
| Colombia | 5611079 | APARATO DISPENSADOR Y CAPSULA | See Plans and Pricing |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2022 - 2023
NCE-1 Patent Challenge Dates 2022 - 2023
ClinicalTrialExchange - Connecting volunteers and trials
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2022, www.DrugPatentWatch.com.
Follow DrugPatentWatch:
